Motus GI Revenue and Competitors

Miami, FL USA

Location

$50M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Motus GI's estimated annual revenue is currently $7.8M per year.(i)
  • Motus GI's estimated revenue per employee is $215,278
  • Motus GI's total funding is $50M.

Employee Data

  • Motus GI has 36 Employees.(i)
  • Motus GI grew their employee count by -28% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$13.6M8840%N/AN/A
#2
$1.4M929%N/AN/A
#3
$3.6M23-12%N/AN/A
#4
$4.5M2912%N/AN/A
#5
$2.5M16N/AN/AN/A
#6
$0.9M6200%N/AN/A
#7
$1.4M9-18%N/AN/A
#8
$3.7M24-11%N/AN/A
#9
$2.5M16-11%N/AN/A
#10
$0.9M620%N/AN/A
Add Company

Motus GI Holdings, Inc. (NASDAQ: MOTS) is a medical technology company based in the U.S., with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System, designed to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The Pure-Vu® System is a 510(k) U.S. Food and Drug Administration cleared medical device indicated to help facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The device integrates with standard colonoscopes to enable cleaning during the procedure while preserving standard procedural workflow and techniques. The Pure-Vu® System has received CE mark approval in Europe.

keywords:N/A

$50M

Total Funding

36

Number of Employees

$7.8M

Revenue (est)

-28%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Motus GI News

2022-04-17 - Motus GI Completes Enrollment in the European Union Feasibility ...

Motus GI Completes Enrollment in the European Union Feasibility Study of the Pure-Vu® System as a New Method for Bowel Cleansing in Patients...

2022-03-22 - Motus GI Reports Fourth Quarter and Full Year 2021 Financial ...

Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve...

2022-03-22 - Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q4 2021 Results - Earnings Call Transcript

Motus GI Holdings, Inc. (NASDAQ:MOTS) Q4 2021 Earnings Conference Call March 29, 2022 4:30 PM ET. Company Participants.

2021-07-21 - Motus GI : Secures Expanded $12M Credit Financing to Support Growth Strategy (Form 8-K)

Motus GI Secures Expanded $12M Credit Financing to Support Growth Strategy FORT LAUDERDALE, FL., July 21, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ('Motus GI' or the 'Company'), a medical technology company providing endoscopy solutions that improve clinical outcomes and ...

2021-07-21 - Motus GI Secures Expanded $12M Credit Financing to Support Growth Strategy

FORT LAUDERDALE, Fla., July 21, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management o ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M36-16%N/A
#2
$4.3M36-18%N/A
#3
$9.3M363%N/A
#4
$6M36-3%N/A
#5
$7.8M3671%N/A